Double-Blind Naltrexone in Kleptomania

Completed · Phase 2 · Has a placebo group

Conditions studied: Kleptomania

In brief

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in kleptomania.

Key facts

Study ID

NCT00332579

Run by

University of Minnesota

People needed

25

Starts

2006-05-01

Expected to finish

2008-09-01

Last updated by the study team

2019-07-29

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• men and women age 21-75
• current DSM-IV kleptomania.

You may not qualify if…

• unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination
• history of seizures
• myocardial infarction within 6 months
• current pregnancy or lactation, or inadequate contraception in women of childbearing potential
• clinically significant suicidality
• current or recent (past 3 months) DSM-IV substance abuse or dependence
• illegal substance within 2 weeks of study initiation
• initiation of psychotherapy or behavior therapy from a mental health professional for the treatment of kleptomania within 3 months prior to study baseline
• initiation of a psychotropic medication within 2 months prior to study inclusion
• previous treatment with naltrexone
• treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline.

Where it is running

• University of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.